Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Not yet recruiting × Carcinoma, Ductal × Clear all

Phase

Status

Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 121 Breast Neoplasms 97 Carcinoma, Hepatocellular 62 Colorectal Neoplasms 61 Stomach Neoplasms 49 Squamous Cell Carcinoma of Head and Neck 49 Triple Negative Breast Neoplasms 45 Lung Neoplasms 42 Prostatic Neoplasms 41 Small Cell Lung Carcinoma 36 Leukemia, Myeloid, Acute 36 Uterine Cervical Neoplasms 35 Rectal Neoplasms 35 Pancreatic Neoplasms 32 Neoplasms 30 Recurrence 29 Esophageal Squamous Cell Carcinoma 25 Ovarian Neoplasms 24 Neoplasm Metastasis 24 Brain Neoplasms 24 Esophageal Neoplasms 22 Lymphoma, Large B-Cell, Diffuse 20 Nasopharyngeal Carcinoma 19 Head and Neck Neoplasms 19 Colonic Neoplasms 19 Multiple Myeloma 18 Melanoma 18 Glioblastoma 18 Endometrial Neoplasms 18 Carcinoma, Renal Cell 18

Interventions

exemestane 1 Tamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07499999 2026-03-30

BabyTEARS

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Breast Neoplasms, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡